108 related articles for article (PubMed ID: 24371920)
1. Polyamine inhibitors for treatment of feline oral squamous cell carcinoma: a proof-of-concept study.
Lewis JR; O'Brien TG; Skorupski KA; Krick EL; Reiter AM; Jennings MW; Jurney CH; Shofer FS
J Vet Dent; 2013; 30(3):140-5. PubMed ID: 24371920
[TBL] [Abstract][Full Text] [Related]
2. Phase I/II clinical trial of 2-difluoromethyl-ornithine (DFMO) and a novel polyamine transport inhibitor (MQT 1426) for feline oral squamous cell carcinoma.
Skorupski KA; O'Brien TG; Guerrero T; Rodriguez CO; Burns MR
Vet Comp Oncol; 2011 Dec; 9(4):275-82. PubMed ID: 22077408
[TBL] [Abstract][Full Text] [Related]
3. Enhanced tissue polyamine content in the spontaneously hypertensive rat.
Ibrahim J; Hughes AD; Schachter M; Sever PS
Clin Exp Pharmacol Physiol; 1996 May; 23(5):410-4. PubMed ID: 8713680
[TBL] [Abstract][Full Text] [Related]
4. Relationship between heat sensitivity and polyamine levels after treatment with alpha-difluoromethylornithine (DFMO).
Mivechi NF; Dewey WC; Feuerstein BG; Deen DF; Marton LJ
Radiat Res; 1986 Dec; 108(3):269-81. PubMed ID: 3099327
[TBL] [Abstract][Full Text] [Related]
5. Depletion of polyamines and increase of transforming growth factor-beta1, c-myc, collagen-type I, matrix metalloproteinase-1, and metalloproteinase-2 mRNA in primary human gingival fibroblasts.
Stabellini G; Moscheni C; Gagliano N; Dellavia C; Calastrini C; Ferioli ME; Gioia M
J Periodontol; 2005 Mar; 76(3):443-9. PubMed ID: 15857080
[TBL] [Abstract][Full Text] [Related]
6. Polyamine contents in rectal and buccal mucosae in humans treated with oral difluoromethylornithine.
Boyle JO; Meyskens FL; Garewal HS; Gerner EW
Cancer Epidemiol Biomarkers Prev; 1992; 1(2):131-5. PubMed ID: 1306095
[TBL] [Abstract][Full Text] [Related]
7. [Oral squamous cell carcinoma in a cat].
Teske E; Rutteman GR
Tijdschr Diergeneeskd; 2005 Dec; 130(24):764-6. PubMed ID: 16395960
[No Abstract] [Full Text] [Related]
8. Palliative radiation therapy outcomes for cats with oral squamous cell carcinoma (1999-2005).
Sabhlok A; Ayl R
Vet Radiol Ultrasound; 2014; 55(5):565-70. PubMed ID: 24766180
[TBL] [Abstract][Full Text] [Related]
9. Computed tomographic features of oral squamous cell carcinoma in cats: 18 cases (2002-2008).
Gendler A; Lewis JR; Reetz JA; Schwarz T
J Am Vet Med Assoc; 2010 Feb; 236(3):319-25. PubMed ID: 20113245
[TBL] [Abstract][Full Text] [Related]
10. Urinary polyamine levels in cancer patients treated with D,L-alpha-difluoromethylornithine, an inhibitor of polyamine biosynthesis.
Horn Y; Spigel L; Marton LJ
J Surg Oncol; 1989 Jul; 41(3):177-82. PubMed ID: 2501593
[TBL] [Abstract][Full Text] [Related]
11. Treatment of oral squamous cell carcinoma with accelerated radiation therapy and concomitant carboplatin in cats.
Fidel J; Lyons J; Tripp C; Houston R; Wheeler B; Ruiz A
J Vet Intern Med; 2011; 25(3):504-10. PubMed ID: 21539605
[TBL] [Abstract][Full Text] [Related]
12. Use of cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum (II), a liposomal cisplatin analogue, in cats with oral squamous cell carcinoma.
Fox LE; Rosenthal RC; King RR; Levine PB; Vail DM; Helfand SC; MacEwen EG; Perez-Soler R; Calderwood-Mays M; Kurzman ID
Am J Vet Res; 2000 Jul; 61(7):791-5. PubMed ID: 10895902
[TBL] [Abstract][Full Text] [Related]
13. Tolerability of toceranib phosphate (Palladia) when used in conjunction with other therapies in 35 cats with feline oral squamous cell carcinoma: 2009-2013.
Olmsted GA; Farrelly J; Post GS; Smith J
J Feline Med Surg; 2017 Jun; 19(6):568-575. PubMed ID: 26951557
[TBL] [Abstract][Full Text] [Related]
14. Depletion of intracellular polyamine content does not alter the survival of 9L rat brain tumour cells after X-irradiation.
Seidenfeld J; Deen DF; Marton LJ
Int J Radiat Biol Relat Stud Phys Chem Med; 1980 Aug; 38(2):223-9. PubMed ID: 6776070
[No Abstract] [Full Text] [Related]
15. Study of feline oral squamous cell carcinoma: potential target for cyclooxygenase inhibitor treatment.
DiBernardi L; Doré M; Davis JA; Owens JG; Mohammed SI; Guptill CF; Knapp DW
Prostaglandins Leukot Essent Fatty Acids; 2007 Apr; 76(4):245-50. PubMed ID: 17383864
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy with 2-difluoromethylornithine and a polyamine transport inhibitor against murine squamous cell carcinoma.
Chen Y; Weeks RS; Burns MR; Boorman DW; Klein-Szanto A; O'Brien TG
Int J Cancer; 2006 May; 118(9):2344-9. PubMed ID: 16331620
[TBL] [Abstract][Full Text] [Related]
17. Effects of inhibitors of ornithine and S-adenosylmethionine decarboxylases on L6 myoblast proliferation.
Stoscheck CM; Erwin BG; Florini JR; Richman RA; Pegg AE
J Cell Physiol; 1982 Feb; 110(2):161-8. PubMed ID: 6802862
[TBL] [Abstract][Full Text] [Related]
18. Preliminary evaluation of bleomycin in feline and canine squamous cell carcinoma.
Buhles WC; Theilen GH
Am J Vet Res; 1973 Feb; 34(2):289-91. PubMed ID: 4119568
[No Abstract] [Full Text] [Related]
19. COX-1 and COX-2 expression in feline oral squamous cell carcinoma.
Hayes A; Scase T; Miller J; Murphy S; Sparkes A; Adams V
J Comp Pathol; 2006; 135(2-3):93-99. PubMed ID: 16952367
[TBL] [Abstract][Full Text] [Related]
20. Alpha-difluoromethylornithine as treatment for metastatic breast cancer patients.
O'Shaughnessy JA; Demers LM; Jones SE; Arseneau J; Khandelwal P; George T; Gersh R; Mauger D; Manni A
Clin Cancer Res; 1999 Nov; 5(11):3438-44. PubMed ID: 10589756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
